iCAD to Report First Quarter 2020 Financial Results on Monday, May 11
Rhea-AI Summary
iCAD announced its Q1 2020 financial results will be released after market close on May 11, 2020. The company will hold a conference call at 4:30 PM ET on the same day to discuss the results. This call will be accessible through a domestic number (888-394-8218) and an international line (323-794-2588). The conference ID is 6904669, and a webcast will be available for interested parties. iCAD specializes in innovative solutions for cancer detection and therapy.
Positive
- Upcoming release of financial results may provide insights into growth and performance.
- Scheduled conference call indicates ongoing communication with investors.
Negative
- None.
News Market Reaction – ICAD
In the trading session that priced this news, ICAD declined 1.13%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NASHUA, N.H. , May 05, 2020 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the first quarter ended March 31, 2020, after the market close, and host a conference call at 4:30 pm Eastern Time on Monday, May 11.
| Monday, May 11th @ 4:30pmET | |
| Domestic: | 888-394-8218 |
| International: | 323-794-2588 |
| Conference ID: | 6904669 |
| Webcast: | http://public.viavid.com/index.php?id=139680 |
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Relations:
Jeremy Feffer, LifeSci Advisors
+ 1-212-915-2568
jeremy@lifesciadvisors.com